Raajadhani Generic Medicines Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2019
- Revenue Growth %
- Profit Growth 30.78%
- Ebitda 70.09%
- Net Worth -933.79%
- Total Assets -11.59%
About Raajadhani Generic Medicines
Raajadhani Generic Medicines Private Limited (RGMPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 April 2017 (Seven years and nine months 6 days old ). Its registered office is in Guntur, Andhra Pradesh, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Lakshmi Kasturi and Satyanarayana Kasturi serve as directors at the Company.
Company Details
-
Location
Guntur, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909AP2017PTC105760
-
Company No.
105760
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Apr 2017
-
Date of AGM
30 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Raajadhani Generic Medicines?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satyanarayana Kasturi
|
Director | 27-Apr-2017 | Current |
|
Lakshmi Kasturi
|
Director | 27-Apr-2017 | Current |
Financial Performance of Raajadhani Generic Medicines.
Raajadhani Generic Medicines Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 30.78% increase in profit. The company's net worth observed a substantial decline by a decrease of 933.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Raajadhani Generic Medicines?
Unlock access to Raajadhani Generic Medicines's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Infokeen Digital Solutions Private LimitedLakshmi Kasturi and Satyanarayana Kasturi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Raajadhani Generic Medicines?
Unlock and access historical data on people associated with Raajadhani Generic Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Raajadhani Generic Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raajadhani Generic Medicines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
